Real-time PCR for pharmacodynamic studies of Chlamydia trachomatis

Journal of Microbiological Methods

Volumn 61, Issue 3, 2005, Pages 361-367

  Storm, Martin ^a,b   Gustafsson, Ingegerd ^a   Herrmann, Björn ^a,b   Engstrand, Lars ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Antibiotics; C. trachomatis; MIC; Persistence; Pharmacodynamics; Real time PCR; Resistance; Susceptibility testing

Indexed keywords

ANTIBIOTIC AGENT; COMPLEMENTARY DNA; DOXYCYCLINE; RNA;

ARTICLE; BACTERIAL STRAIN; CELL CULTURE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; IMMUNOFLUORESCENCE; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

CHLAMYDIA TRACHOMATIS;

EID: 17644396705     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2004.12.015     Document Type: Article

References (15)

1. K.W. Beagley, and P. Timms Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development J. Reprod. Immunol. 48 2000 47 68
2. W.L. Beatty, G.I. Byrne, and R.P. Morrison Repeated and persistent infection with chlamydia and the development of chronic inflammation and disease Trends Microbiol. 2 1994 94 98
3. S.A. Bustin Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems J. Mol. Endocrinol. 29 2002 23 39
4. N.A. Cross, D.J. Kellock, G.R. Kinghorn, M. Taraktchoglou, E. Bataki, K.M. Oxley, P.M. Hawkey, and A. Eley Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase pcr-based method Antimicrob. Agents Chemother. 43 1999 2311 2313
5. D. Dean, R.J. Suchland, and W.E. Stamm Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping J. Infect. Dis. 182 2000 909 916
6. S. Dessus-Babus, C.M. Bebear, A. Charron, C. Bebear, and B. de Barbeyrac Sequencing of gyrase and topoisomerase iv quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained in vitro Antimicrob. Agents Chemother. 42 1998 2474 2481
7. U. Dreses-Werringloer, I. Padubrin, B. Jurgens-Saathoff, A.P. Hudson, H. Zeidler, and L. Kohler Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro Antimicrob. Agents Chemother. 44 2000 3288 3297
8. U. Dreses-Werringloer, I. Padubrin, H. Zeidler, and L. Kohler Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro Antimicrob. Agents Chemother. 45 2001 3001 3008
9. I. Gustafsson, E. Hjelm, and O. Cars In vitro pharmacodynamics of the new ketolides HMR3004 and HMR3647 (telithromycin) against Chlamydia pneumoniae Antimicrob. Agents Chemother. 44 2000 1846 1849
10. R.J. Hogan, S.A. Mathews, S. Mukhopadhyay, J.T. Summersgill, and P. Timms Chlamydial persistence: beyond the biphasic paradigm Infect. Immun. 72 2004 1843 1855
11. J.C. Lefevre, J.P. Lepargneur, D. Guion, and S. Bei Tetracycline- resistant Chlamydia trachomatis in Toulouse, France Pathol. Biol. (Paris) 45 1997 376 378
12. J. Lenart, A.A. Andersen, and D.D. Rockey Growth and development of tetracycline-resistant Chlamydia suis Antimicrob. Agents Chemother. 45 2001 2198 2203
13. C. Nystrom-Rosander, K. Hulten, I. Gustavsson, O. Cars, L. Engstrand, and E. Hjelm Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations Scand. J. Infect. Dis. 29 1997 513 516
14. J. Somani, V.B. Bhullar, K.A. Workowski, C.E. Farshy, and C.M. Black Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure J. Infect. Dis. 181 2000 1421 1427
15. R.J. Suchland, W.M. Geisler, and W.E. Stamm Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp Antimicrob. Agents Chemother. 47 2003 636 642